LORICRIN and melanoma: However, strikingly, when epidermal loricrin expression was combined with epidermal AMBRA1 expression, the results revealed that decreased peritumoral expression of both markers was associated with 100% sensitivity and specificity for identifying truly high‐risk melanomas in this subcohort (Fig. S6; see Supporting Information).